Kailera Therapeutics Inc., a clinical-stage biotechnology company, will make its debut on the Nasdaq on April 17, 2026, under the ticker symbol "KLRA".
The company is offering 39.06 million shares of its common stock in the IPO, priced at $16 each. The offering is slated to close on April 20, 2026, with gross proceeds of $625.0 million.
For comments and feedback contact: editorial@rttnews.com
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.